Skip to content
Menu
Home
about AesMed
AesMed Story
AGF39
Cytokine Therapy for Inhibition of DHT-Induced Hair Loss and Normalization of the Anagen Phase
2025-04-25
How AesMed’s AGF39™ Supports Hair Regeneration Hair loss is a common issue affecting ...
Read More
Latest Posts
Medical Procedure for Alopecia Treatment
Home Scalp Care for Alopecia Treatment
AesMed at interCHARM KOREA 2025
Alopecia Treatment Using Drugs: Exploring Medical Solutions for Hair Loss
AesMed at KSHRS 2025: Advancing Hair Restoration with CytoMesopecia
AesMed Highlights from KALDAT 2025: Sharing Innovation in Hair Science
Basic Causes of Alopecia & the Hair Cycle
History & KOL of AesMed: Shaping the Future of Hair Restoration
AesMed at Three Major Conferences in May 2025: Join Us in Shaping the Future of Hair Restoration
Cytokine Therapy for Inhibition of DHT-Induced Hair Loss and Normalization of the Anagen Phase
Search for:
